Archive for March, 2019
Vancouver, British Columbia–(March 12, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce the appointment of new Director, Mr. Steve Giblin. Mr. Giblin is an accomplished leader in the Global hospitality, technology and real estate industries with a demonstrated track record of value creation.
Mr. Giblin has strong C suite relationships with Marriott, Hilton, and Radisson brands and he managed the Silverbirch and Delta hotel real estate portfolios for the British Columbia Investment Management Corporation. As CEO of Silverbirch, he grew revenues from $280m up to $500m and increased the portfolio value over 50%. He has worked closely with other companies including established brands like that of Bentall Kennedy, Great West Life and general contractors, Ellis Don, PCL and Bird.
“We’re extremely pleased to welcome Steve to our team. His Expertise managing complex businesses in competitive markets and the breadth of his experience will assist us in our growth initiative and follow through on our corporate governance initiatives.” stated Jim Pakulis CEO.
“I am looking forward to working with The Management and the board to create value for our investors and continue to grow the company. I recognize the unique position that TransCanna represents and firmly believe the opportunities Mr. Pakulis has identified in the California market place can be addressed.” added Mr. Giblin.
Mr. Giblin will be replacing Mr. John Dacosta. The company wishes to thank Mr. Dacosta for his support and efforts in helping the company launch.
This press release does not constitute an offer to sell or solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About Transcanna Holdings Inc.
TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.
For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.
On behalf of the Board of Directors,
Mr. James Pakulis
President and Chief Executive Officer
For Investor Information please email info@transcanna.com
Telephone: (604) 609-6199
The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the expected purchase of the facility, the terms of the facility acquisition, the payment of finders fees in relation thereto, the ability of the Company to secure financing and the acquisition of appropriate licenses for the facility. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
CannabisNewsWire Editorial Coverage: Individuals hoping to gain exposure to the movement of the markets have two primary options: spend a lot of time and effort researching public companies, or put faith into a fund. A solid investment strategy is key to keeping pace with inflation and reaching your financial goals, but the significant risk and volatility that can come with investing in a small group of companies is a real turn-off for most part-time investors.
Increasingly, novices and seasoned traders alike are turning to mutual funds for their stability and ease of use. According to data from the Investment Company Institute, mutual funds were the most common type of investment company owned in 2018, with 44.8 percent of U.S. households owning shares of mutual funds or similar U.S.-registered investment companies – including exchange-traded funds (ETFs), closed-end funds and unit investment trusts. As Matthew P. Fink notes in The Rise of Mutual Funds: An Insider’s View, “Today U.S. mutual funds are…
Read more »
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
- Cannabis industry job postings rose 445 percent in 2017
- Cannabis Strategic Ventures poised to meet this growing demand through multiple diverse subsidiaries
- PureOrganix, one such subsidiary, offers top-quality products that meet strict health and safety specifications
Cannabis Strategic Ventures Inc. (OTC: NUGS), a company focused on supporting entrepreneurial growth in the legal cannabis sector, offers personnel solutions to equip cannabis industry purveyors with the staffing resources that they need to achieve continued growth. Serving all vertical layers of the cannabis industry, Cannabis Strategic Ventures customizes its staffing services to each company’s individual needs, servicing cultivators, manufacturers, dispensaries and others in the cannabis marketplace.
The company aims to garner a corner of the $10 billion cannabis and $900 million hemp industries. In its approach, Cannabis Strategic Ventures has cultivated a…
Read more »
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
The House Judiciary Committee in Kentucky voted on Wednesday (March 6) to pass a bill that would legalize medical cannabis in the state. The bill will now be sent to the Rules Committee of the Assembly.
House Bill 136 was co-sponsored by 43 members out of the 100 members in the entire lawmaking chamber. This bill intends to create a Department for Alcoholic Beverage and Cannabis Control. This agency will then design a medical cannabis program for the state.
The agency will also be responsible for giving medical marijuana licences to patients who meet the criteria for such a licence. Healthcare providers, processors, cultivators and dispensaries will also be regulated by this agency.
16 legislators on the House Judiciary Committee voted in favor of the bill while one lawmaker voted against it.
Opinion polls in the state show that 80 percent of all adults think that it is okay to allow patients to have the option of using medical cannabis if their doctors recommend it. Governor Matt Bevin has also expressed his support for medical marijuana.
Despite that support from the public and the Governor, attempts to legalize medical marijuana in the state still have major hurdles to overcome.
For example, Robert Stivers, the Senate President, has been vocal in opposing medical cannabis. He even went as far as comparing it to alcohol, saying that anyone who wanted to feel better or relax can take a glass or bourbon instead of consuming medical marijuana.
The Kentucky Medical Association is also adamant that it will only support medical cannabis legislation once the Food and Drug Administration (FDA) approves the use of medical marijuana.
The sponsors of this legalization bill are aware of this strong opposition and made a number of modifications to the bill in order to build some consensus around it.
For example, the original bill had provisions that would allow patients enrolled on the medical marijuana program to grow a maximum of six mature plants for their own use. This was dropped from the bill.
Another change that was made regarded the qualifying conditions for which a patient could use medical marijuana. Originally, the framers of the bill had wanted doctors to use their discretion to decide which patient would benefit from medical cannabis. The bill was amended to create a specific list of conditions for which patients could be treated using medical marijuana.
It is now up to the Rules Committee to decide whether House Bill 136 can now be put before the entire House for a vote. A decision must be made quickly, since this legislative session only has five more days before it ends.
Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) hope that the legislators make the best decision within the limited time left so that patients don’t have to wait longer for a treatment option that is already available in other states.
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
TORONTO, March 11, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that it has entered into a multi-year extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF) (“Valens“).
Valens is a licenced provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies. Partnering with Valens will accelerate TGOD’s Canadian hemp strategy and allow for early market entry of TGOD’s organic hemp-derived CBD product lines within the coming months.
Under the terms of the initial 2-year agreement, Valens will process, extract and purify TGOD’s cannabis and hemp biomass under conditions specified by TGOD as demanded by final product manufacturing and formulation requirements. TGOD will supply Valens with significant quantities of cannabis and hemp and Valens will provide extraction purification services processing the cannabis and hemp into premium quality resins and distillates. TGOD intends to use the concentrated cannabinoid resins and distillates to produce oils, sprays and capsules as well as oils for vaporization and future edible, beverage and topical products.
TGOD has been working closely with Valens to help expedite the pathway to organic certification for Valens organic processing methodologies. Upon certification, TGOD will have exclusive access to services provided by Valens for certified organic extraction processing for a period of 1 year.
The demand for non-intoxicating hemp-derived CBD products has been strong and supported through significant patient and consumer research. Being first to market in Canada with organically certified hemp-derived CBD products allows TGOD to capture organic CBD market share securing future growth in this newly legalized cannabinoid vertical.
“The ability to partner with skilled and specialized extraction operators such as Valens will add significant bench strength to TGOD’s already robust extraction capabilities in Canada, Poland and Jamaica. We believe the importance of high-quality cannabis oils will continue to greatly increase as patients and consumers look for safer and healthier delivery methods.”
“We are excited to work with TGOD, Canada’s premier certified organic producer,” said Tyler Robson, CEO of Valens. “Organic resonates with consumers, and Valens looks forward to helping accelerate TGOD’s time to market with the launch of its hemp-derived CBD product line in the coming months.”
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
About Valens GroWorks
Valens GroWorks Corp. is a research-driven, vertically integrated Canadian cannabis company focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification, as well as associated quality testing with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech (“VAL”) holds a license to cultivate cannabis and produce cannabis oil under the Cannabis Act, as well as a license to conduct analytical testing for the cannabis industry. VAL currently has extraction processing and supply agreements with various leading producers across Canada. Subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science. Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or adult usage purposes. For more information, please visit http://valensgroworks.com. The Company’s investor deck can be found specifically at http://valensgroworks.com/investors/
For further information, please contact:
Scott Young
Valens GroWorks Corp.
Telephone: +1.705.888.2756
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about future facility construction and capital costs, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, revenue and cashflows, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
CannabisNewsWire Editorial Coverage: Individuals hoping to gain exposure to the movement of the markets have two primary options: spend a lot of time and effort researching public companies, or put faith into a fund. A solid investment strategy is key to keeping pace with inflation and reaching your financial goals, but the significant risk and volatility that can come with investing in a small group of companies is a real turn-off for most part-time investors.
Increasingly, novices and seasoned traders alike are turning to mutual funds for their stability and ease of use. According to data from the Investment Company Institute, mutual funds were the most common type of investment company owned in 2018, with 44.8 percent of U.S. households owning shares of mutual funds or similar U.S.-registered investment companies – including exchange-traded funds (ETFs), closed-end funds and unit investment trusts. As Matthew P. Fink notes in The Rise of Mutual Funds: An Insider’s View, “Today U.S. mutual funds are…
Read more »
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000
For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.
Youngevity International Inc. (NASDAQ: YGYI), an emerging conglomerate operating in three distinct business segments, this morning announced that it will be presenting at the second annual LD Micro Virtual Conference on Tuesday, March 12 at 4:00 pm EST. Per the update, Dave Briskie, president and CFO of YGYI, will be giving the presentation and answering questions from investors. “We are enthusiastic to be presenting at LD Micro’s virtual event and the timing could not be better for YGYI to be making a presentation to the investment community,” Briskie stated in the news release. “We just acquired Khrysos Industries, which we anticipate will provide multiple revenue opportunities in the Hemp Based CBD space. This will be our first formal presentation since this strategic acquisition.”
To access the presentation, visit http://nnw.fm/5BUxT
To view the full press release, visit: http://nnw.fm/Xnvm0
About Youngevity International Inc.
Youngevity International Inc., an emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated Hemp based product development enterprise including end to end processing, and a Direct Selling Enterprise that consists of an expanding portfolio of consumer brands developed with its in-house product development team and distributed by traditional and non-traditional channels, including a multi country direct selling network. For more information, visit the company’s website at www.YGYI.com
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- Cannabis Strategic Ventures focuses on building category leaders within the cannabis and CBD space
- It has varied subsidiaries that advance its goal of molding the future of the cannabis marketplace
- The company recently obtained a $3 million investment for business and operations expansion
Cannabis Strategic Ventures Inc. (OTC: NUGS) concentrates on supporting entrepreneurial growth within the emerging legal cannabis sector. It acquires, incubates, develops and partners with brands on a global scale to build category leaders within the cannabis and CBD (cannabidiol) space. The company has a portfolio of subsidiaries that comprise The Asher House Wellness, Budhire, Fitamins, LYXR, Halo Filters and Pure Applied Sciences Inc. Cannabis Strategic Ventures is headquartered in Los Angeles, California.
The company offers outsourced personnel solutions custom-made to match the growth potential of cannabis cultivators, manufacturers, dispensaries and other participants in the cannabis market. Furthermore, Cannabis Strategic Ventures engages in investment opportunities in the real estate, cultivation, extraction, distribution, packaging, dispensary operations and…
Read more »
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
COLUMBUS, OH, March 8, 2019 – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or “the Company”) today announced issuance of shares of common stock for completed consulting services with JDS 4300 Consulting LLC (“JDS”) and TSB Consulting LLC (“TSB”) for arm’s length previously-rendered strategic corporate advisory and corporate structure and reorganization services, respectively. In exchange for the services rendered under these agreements, the Company has issued to JDS USD$687,469.31 (CAN$924,000) in GGB common shares, and has issued to TSB USD$171,867.33 (CAN$231,000) in GGB common shares, with the price of each share issuance reflecting the GGB share price of USD$3.44 (CAN$4.62) as of the close of trading on March 6, 2019. The common shares for both agreements are subject to a lock up agreement for a period of 12 months from the effective date.
About Green Growth Brands
Green Growth Brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love. Led by Peter Horvath, the GGB team is full of retail and consumer packaged goods experts with decades of experience building successful brands. Join the movement at GreenGrowthBrands.com.
Cautionary Statements:
Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.
The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act“), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.
Dynamic plant-based food and beverage company Canopy Rivers (TSXV: RIV) Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) on Thursday announced that its portfolio company, Headset, Inc., formed a landmark strategic alliance with Nielsen Holdings plc (NYSE: NLSN). According to the update, the partnership combines Nielsen’s consumer research capabilities with Headset’s real-time retail point-of-sale platform to provide U.S. cannabis market data and analytics to consumer packaged goods (“CPG”) companies monitoring the cannabis space. “This announcement from Headset and Nielsen validates our belief in the importance of data in the rapidly unfolding and brand-intensive cannabis industry,” Canopy Rivers President Narbe Alexandrian said in the news release. “Partnering with Nielsen, an S&P 500 company and global market leader in consumer data and insights, marks a significant step forward for Headset in its goal to help companies make more informed business decisions through data.”
To view the full press release, visit: http://nnw.fm/vAfd7
About Canopy Rivers Inc.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Cannabis industry incubator Cannabis Strategic Ventures (OTC: NUGS) recently strengthened its portfolio with the addition of the six-acre Northern California NUGS Farm. An article discussing the company reads, “The company began the new year with an application for uplisting to the Venture Market and followed that with the announcement that it will partner with a Santa Barbara County cultivation operation that holds about 40 commercial cannabis licenses in Southern California. On January 30, Cannabis Strategic Ventures revealed that it will add the six-acre Northern California site after having obtained over 20 licenses for cannabis manufacturing, distribution and cultivation (http://nnw.fm/aJ72J). . . . ‘Establishing the NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures. We are proud of what we have accomplished at this stage of the company,’ CEO Simon Yu stated in a news release. ‘As the cannabis industry expands, and as we work to make cannabis legal on a federal level, Cannabis Strategic Ventures will be in position to touch on all areas of cannabis production.’”
To view the full article, visit: http://nnw.fm/sZ5f8
About Cannabis Strategic Ventures Inc.
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Palm Beach, FL – March 7, 2019 – In an article titled: “The Economics of Extraction” the Cannabis Business Times (CBT) predicted that consumers will demand more and more retail choices: “CBT reported that vape cartridge sales in California reached $100 million for the combined months of November and December 2017. The next bestselling concentrate product during that time was wax, with $7.4 million in sales. The stated total of all concentrate revenue in California for that same period was $140.9 million… Based on those figures, it’s clear that vape cartridges dominate sales. But why? The simple answer: user convenience.” The article continued: “With this data, some companies will successfully focus strictly on cartridge sales, but the cartridge industry is destined to become competitive and saturated. Everyone has, or will soon have, their own branded cartridge without a strategic advantage like a rare cultivar, proprietary device, or efficient and/or superior extraction methodologies and practices. CBT believes many companies will produce a vape cartridge that is no better nor cheaper than the rest, and these companies will suffer due to little or no brand recognition and will struggle to compete with products that possess strategic advantages (such as the ones mentioned). Therefore, extract companies need to find means to efficiently produce a diversified range of concentrates—and not rely strictly on vape cartridge sales. Active Companies from around the market with current developments this week include: Chemesis International Inc. (CSE: CSI) (OTC: CADMF), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), HEXO Corp. (NYSE: HEXO) (TSX: HEXO), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD), Tilray, Inc. (NASDAQ: TLRY).
Consumers will ultimately demand a wide range of products and offerings. Future consumers will be educated on cannabis’s nuances and characteristics. In turn, many will prefer to purchase superior- tasting, connoisseur-quality products over artificial or formulated flavors or poor-quality concentrates. If the superior offerings are affordable, that is all the better for the consumer. Extractors need to be mindful not only of a product’s strategic market advantages over another, but also the costs associated with extraction equipment as well as the cost of required basic materials (such as solvents) that can accumulate rapidly and increase production overhead.
Chemesis International Inc. (CSE: CSI) (OTCQB: CADMF) BREAKING NEWS: Chemesis International announces it has entered into binding agreements to acquire 100% of a fully-operational extraction and manufacturing facility in Cathedral City, California (“Facility”). Once completed, this transaction (“Acquisition”) will expand the Company’s processing ability to over 500,000 kg of cannabis annually. The new state-of-the-art facility is fully licensed, and the Acquisition is expected to double the Company’s current capacity to process large amounts of cannabis to extract THC, CBD and other cannabinoid and terpene products.
The Facility is located within close proximity to the Company’s existing licensed extraction facility, which commenced operations this quarter. Upon completion, the Acquisition will permit the Company to operate two fully licensed and commercialized facilities, which is expected to streamline resources for the Company’s controlled expansion plan within the U.S.
The Acquisition will result in the Company acquiring control over the following licenses:
- Cannabis Business Local License, #MCL-17-007-M-18
- Cannabis Business Local License, #MCL-17-007-C-18
- Type 7 Manufacturing License – Adult & Medical Cannabis Products, #CDPH-T00000362
Furthermore, the Company is exploring the possibility of processing hemp at the Facility for full spectrum plant extracts rich in CBD and leveraging the hemp legalization provisions of the 2018 U.S. Farm Bill to capitalize on the expected increased demand for CBD. It has been estimated that the CBD market will have a value of over $2.1 billion by 2020[1]. Legislation is currently pending in California that would accommodate incorporating hemp-derived cannabinoids and terpenes into the currently regulated cannabis supply chain (similar to neighboring legal cannabis states like Oregon), as well as non-THC-infused food, beverages and cosmetics.
“The Company will, upon completion of the Acquisition, significantly increase its production and manufacturing capabilities in the U.S.,” said CEO of Chemesis, Edgar Montero. “The addition of this new facility will allow the Company to extract high-quality cannabinoids and terpenes for use in a wide variety of consumer products. Chemesis will then be able to leverage its existing expertise in extraction, distribution, and sales to continue growing revenues and build long-term value. I believe this expansion will open up considerable new revenue opportunities for the Company when we begin processing hemp,” added Montero.
Under the terms of this acquisition, Chemesis will pay $1,000,000 USD 90 days from closing and issue 4,600,000 shares. The stock is subject to 36-month lock-up/leak-out guidelines. The Acquisition is expected to close on or about March 30, 2019. Read this and more news for Chemesis International at: https://www.financialnewsmedia.com/news-csi/
[1] Hemp Business Journal
In the industry developments and happenings in the market this week include:
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON.TO) this week confirmed that it had sold all of its common shares in the capital of Whistler Medical Marijuana Corporation (“Whistler“), representing approximately 19 percent of Whistler’s issued and outstanding common shares, to Aurora Cannabis Inc. (“Aurora”) for a total purchase price of approximately C$175 million, payable by the issuance of common shares in the capital of Aurora (“Aurora Common Shares”), and subject to certain working capital adjustments and holdbacks (the “Transaction”).
“We’d like to thank and congratulate Whistler for their partnership over the past two years,” said Mike Gorenstein, CEO of Cronos Group. “Whistler’s commitment to creating high-quality products and establishing a premium brand has generated value for consumers and investors alike. We are proud to have been part of their growth and look forward to their progress through this venture.”
HEXO Corp. (NYSE: HEXO) (TSX: HEXO.TO) recently announced that it has entered into a syndicated credit facility with Canadian Imperial Bank of Commerce (“CIBC”), as Sole Bookrunner, Co-Lead Arranger and Administrative Agent and Bank of Montreal as Co-Lead Arranger and Syndication Agent (together with CIBC, the “Lenders”). Under the terms of the credit facility, the Lenders will provide HEXO up to C$65 million of secured debt financing at a rate of interest that is expected to average in the mid-to-high 5% per annum range over its three-year term.
The credit facility consists of a C$50 million term loan and a C$15 million revolving loan, with an uncommitted option to increase the facility by up to C$135 million, subject to the satisfaction of certain customary legal and business conditions. Both loans mature in 2022. HEXO may, at its discretion, repay the balance of the loans without penalty, at any time.
The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF) (TSX: TGOD.TO) this week announced that it has received organic certification from Pro-cert Organic Systems Ltd. (“Pro-cert”). This is the second certification body to endorse TGOD’s organic process at its Hamilton facility.
The Company is committed to the highest standards of organic cultivation of cannabis. TGOD cannabis is grown in soil, without synthetic fertilizers, herbicides or pesticides, and is never irradiated. Canadian consumers have stated that they prefer organic cannabis. In a recent study conducted by Hill & Knowlton, over 50% of recreational consumers stated it was important that their cannabis was organic. When the same question was posed of medical patients, that number increased to 63%.
“Certified-organic provides consumers with the best cannabis experience, and the entire TGOD organization is committed to that standard,” said Brian Athaide, Director and CEO of TGOD.
Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production and distribution, this week announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”) has completed a successful harvest of medical cannabis at the Company’s European Union (EU) Campus in Portugal.
Tilray’s EU Campus in Portugal is a multi-faceted production facility that includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived medical products. To date, Tilray has invested approximately €20 million in the facility, which totals nearly 250,000 square-feet with additional room to expand.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty six hundred dollars for news coverage of the current press release issued by Chemesis International Inc. by a non-affiliated third party FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
TORONTO, March 07, 2019 — Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) congratulates its portfolio company Headset, Inc. (“Headset”) on the formation of its landmark strategic alliance with Nielsen Holdings plc (“Nielsen”) (NYSE: NLSN). Yesterday, Nielsen and Headset together announced an alliance that will provide U.S. cannabis market data and analytics to consumer packaged goods (CPG) companies monitoring the cannabis space.
“This announcement from Headset and Nielsen validates our belief in the importance of data in the rapidly unfolding and brand-intensive cannabis industry,” said Narbe Alexandrian, President of Canopy Rivers. “Partnering with Nielsen, an S&P 500 company and global market leader in consumer data and insights, marks a significant step forward for Headset in its goal to help companies make more informed business decisions through data.”
Through their partnership, Headset and Nielsen will enable CPG companies to better understand and engage with the fast-changing and dynamic cannabis industry. Combining Nielsen’s consumer research capabilities with Headset’s real-time retail point of sale data and proprietary software platform will deliver greater visibility and insight into market-leading trends, consumer sentiment, the competitive product landscape, and potential interaction points within CPG categories. The first product of the Headset and Nielsen relationship will be a U.S.-focused industry report exploring market dynamics, consumer perceptions and motivations, and insights into purchase dynamics. While initially focused on the U.S., Headset and Nielsen also plan on developing a full suite of capabilities for the Canadian market.
About Canopy Rivers Inc.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. Fore more information, please visit www.canopyrivers.com.
Forward-Looking Statements
This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the importance of data in the rapidly unfolding and brand-intensive cannabis industry; Nielsen’s leadership position in consumer data and insights; the ability to enable CPG companies to better understand and engage with the fast-changing and dynamic cannabis industry; the ability to deliver greater visibility and insight into market-leading trends, consumer sentiment, the competitive product landscape, and potential interaction points within CPG categories; Headset and Nielsen’s plans to release a U.S.-focused industry report and a suite of capabilities for the Canadian market; and other expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the ability of brands, retailers marketers and investors to leverage data about the cannabis market; competition in the business intelligence and analytics software space; the ability of Headset and Nielsen to collaborate; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Company’s final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Canopy Rivers Inc.
Karoline Hunter
Sr. Director, Investor Relations & Communications
E-mail: ir@canopyrivers.com
Daniel Pearlstein
Executive Vice President, Strategy
E-mail: daniel@canopyrivers.com
Extraction Technology Leader Becomes Cornerstone Partner of New U.S.-Focused Cannabis Platform
DETROIT, March 6, 2019 — Precision Extraction Corporation (DBA Precision Extraction Solutions, “Precision” or “the Company”), a market leader in cannabis and hemp extraction technology, is pleased to announce it has received a significant capital investment from Rivers Innovations Inc. (“Rivers Innovations”), a private U.S. focused growth capital and strategic support platform founded and advised by the seed investment and strategic advisory group behind Canopy Rivers Inc. (TSXV: RIV).
“We believe Precision is ideally positioned in cannabis and hemp extraction and processing, an area of the value chain that has been an industry bottleneck, and one we believe is poised for considerable growth. The significant domestic footprint and client base that Precision has developed to date makes them the perfect flagship partner for Rivers Innovations to tactfully enter the American market,” said Fabian Monaco, President of Rivers Innovations.
Precision is a specialized equipment manufacturer and service provider that has developed a portfolio of extraction and processing technologies utilized for hemp and cannabis extraction, refinement, and processing. Precision has completed thousands of installations throughout regulated jurisdictions in the United States, Canada, as well as in select European markets.
“Innovation and technological development have always been at the core of our company’s values. The investment from Rivers Innovations will allow our industry-leading team of engineers, product developers, and R&D specialists to scale our business even more quickly, and financially unencumbered. We look forward to leveraging the benefits of this partnership to continue providing disruptive technologies and support services to the globally emerging cannabis and hemp markets,” said Nick Tennant, Founder and Chief Technology Officer of Precision.
Rivers Innovations seeks to enter financial and strategic partnerships with companies operating in high margin, high barrier to entry segments of the cannabis and hemp value chains. Rivers Innovations focuses on investment opportunities and partnerships in the U.S. cannabis industry and other international emerging cannabis markets, in each case, where cannabinoids have been legalized for medicinal, therapeutic or adult-use. As regulations continue to evolve and demand for formulated cannabinoid products continues to increase, both Precision and Rivers Innovations believe that specialized extraction and refinery equipment and service operations will be critical.
“We selected Rivers Innovations as our financial and strategic partner because we share similar industry outlooks, we have complementary strategic relationship networks, and this partnership positions our companies optimally to leverage each other’s strengths. Not only does Rivers Innovations provide access to capital and increased visibility in the capital markets, their ability to integrate expertise and human capital resources into our organization is of tremendous value,” stated Marc Beginin, CEO of Precision.
According to cannabis industry analysts the Brightfield Group, the hemp-CBD market alone could hit $22 billion by 2022. Precision extraction technologies are a key component for CBD oil and isolate production.
Media Contact:
Nicholas Shafer
VP, Marketing and Business Strategy
Precision Extraction Solutions
855-420-0020 x11
nics@precisionextraction.com
SAN DIEGO, March 6, 2019 — Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced the planned launch of coffee infused with CBD. YGYI had been working on a CBD coffee with the launch of its HempFX™ line of full-spectrum CBD products with ambition of being able to provide specific dosing via a K-Cup or single-serve delivery system. The company’s very recent acquisition of Khrysos Industries, and the validation capabilities of its newly acquired INX Labs, helped significantly accelerate the process. YGYI intends to launch two brands taking advantage of its broad distribution capabilities. The HempFX Brand of CBD-infused coffee is expected to begin pre-sales in early May through Youngevity International’s sizeable sales network with full-scale distribution taking place later in the month. YGYI’s wholly-owned subsidiary, CLR Roasters, has already begun retail sales presentations of its Javalution brand of CBD-infused coffee and also anticipates an end-of-May shipping timeframe to retail store shelves.
Dave Briskie, President and CFO of YGYI, stated, “We are enthusiastic that the capabilities of our team at Khrysos Industries is delivering dividends so quickly. We have been perplexed in delivering CBD to a cup of coffee at consistent doses, but now we have a solution that passes the scrutiny of laboratory testing and we are excited to bring these products to market. Our team at Khrysos has cracked the code on the production of water-soluble CBDs.”
Dr. Dwayne Dundore, President of Khrysos Industries, stated, “We believe this technology has broad application in a number of areas of product development and certainly reaches beyond coffee. Our water-soluble CBD technology is deliverable in both powders and liquids which creates a wide opportunity across the product development spectrum.”
“The initial line of coffees for both brands will be available in four profiles including Donut Shop, Dark Roast, House Blend, and French Vanilla – all delivered in a single-serve format yielding 10 milligrams of CBD to the cup,” stated Ernesto Aguila, President of CLR Roasters. “We are extremely pleased with the taste of the product, and the samples that we have provided to a host of retailers have led to strong reviews as well. It is very exciting to bring a new product to market that has so much interest within the coffee beverage category. I have not seen a door opener like this since Javalution Coffee Company created the first fortified coffees.”
About CLR Roaster
Youngevity’s coffee manufacturing division, CLR Roasters, was established in 2001 and is a wholly-owned subsidiary. CLR Roasters is a full-sized coffee roaster that produces gourmet coffees under its own boutique brands — Café La Rica®, Josie’s Java House®, and Javalution®; manufactures a variety of private labels for major national chains; and for the direct selling channel under Youngevity International. The company remains one of the largest suppliers in North America to the cruise line industry. CLR was the first entrant into the fortified coffee niche with its Youngevity JavaFit® brand. In May 2014, CLR acquired a coffee plantation and processing facility in Nicaragua, allowing the entity to control coffee production and quality — from field to cup.
About Youngevity International, Inc.
YGYI, Inc. (NASDAQ:YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.
To receive future press releases via email, please visit: https://ygyi.com/investors/email-alerts/
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and includes statements regarding the intended launch of the HempFX Brand and Javalution Brand of CBD-infused coffee, HempFX Brand CBD-infused coffee beginning pre-sales in early May through Youngevity International’s sales network and the technology having broad application in a number of areas of product development.. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to launch the HempFX Brand and Javalution Brands of CBD-infused coffee as planned, our ability to begin pre-sales of HempFX Brand CBD-infused coffee in early May through Youngevity International’s sales network, our ability to apply the technology in other areas of product development,, our ability to continue our coffee segment growth, our ability to continue our international growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to continue our financial performance and the other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2017 and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.
Contacts
Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500
Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com
Media Contact
Dwain Schenck
Schenck Strategies
203-223-5230
dwain@schenckstrategies.com
PHOENIX, AZ / March 6, 2019 / Uptick Newswire Stock Day Podcast welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The Company’s President and CEO, Mr. Richard T. Schumacher, joined Stock Day host Mr. Everett Jolly to discuss the Company’s progress in developing its unique and proprietary Ultra Shear Technology (UST) platform, and the use of this platform to process Hemp CBD Oil into a water-soluble ”nanoemulsion”.
A short video of the UST process and its ability to make Hemp CBD Oil water soluble can be seen on the Pressure BioSciences website (www.pressurebiosciences.com).
Mr. Jolly began the interview by reminding listeners that he had been saying for months that PBI was severely undervalued and that investors should consider adding PBIO to their portfolios. He then pointed out that PBIO has had a very exciting few weeks on the market, during which time the stock’s volume had increased 10x or more and the stock price had nearly doubled. He concluded his opening remarks by stating that he felt the stock still remained significantly under-valued, even at these new levels.
Mr. Jolly then asked Mr. Schumacher to remind listeners what the Company does. Mr. Schumacher commented: ”We are a technology company. We are focused on incorporating the significant benefits of high-pressure in our products, which are mainly comprised of instruments and associated consumables.” He continued by stating that the Company has over 200 customers – many of whom are well-known bio-pharmaceutical companies, academic laboratories, and world-class research scientists and that these customers have purchased over 300 high-pressure instruments to date.
Mr. Schumacher shared that the high-pressure applications and technologies offered by the Company represent a major paradigm shift from laboratory and processing methods of just a few years ago and that this issue has made it difficult for the Company’s products to be accepted by research scientists. However, with publications and presentations from Key Opinion Leaders on the features and benefits of PBI’s pressure-based products finally taking root after years of education and a multitude of supportive data, sales are increasing, interest in PBIO has never been higher, and the future looks bright for our Company.
Mr. Schumacher then highlighted the Company’s newest technology platform, Ultra Shear Technology (UST), which he said combines very high pressure with intense shearing (cutting) forces, resulting in a proprietary processing method unlike anything on the market today. As an example of the power of the UST method, he used the example of oil and water – generally, they do not mix, but after processing with UST, during which time oil drops are broken down into tiny droplets far smaller than the original large drops. Subsequently, the oil becomes water-soluble and readily mixes with and disappears into the water. Mr. Schumacher stressed that this ability to make oil go into water is based on physics (cutting the oil drops into minuscule droplets) and not chemistry (no need to add a lot of chemicals).
Mr. Schumacher further stressed that this capability is incredibly useful in the CBD space, and has generated a lot of excitement. This is because CBD comes out of the cannabis plant in an oil, but because animals (including humans) are unable to digest oil very well, and because the CBD molecule is inside the oil drop, very little of the CBD is actually absorbed when CBD Oil is ingested. Conversely, when CBD is presented to the body in tiny droplets (as a ”nanoemulsion” after UST processing), the absorption rate is dramatically higher. Mr. Schumacher indicated they believe that UST is the answer to one of the major problems in CBD infused products today – how to make CBD Hemp Oil water soluble.
Mr. Schumacher reiterated that the Company had released a short video illustrating this process and showing its water solubility in a press release on February 13th of this year.
Mr. Jolly then asked if PBI had seen an increase in interest because of the recent UST accomplishments, as well as its successes in other parts of the business. Mr. Jolly used as an example the news released earlier in the day regarding a new partnership with The Steinbeis Centre in Germany, and the revolutionary technology that the Company was developing with this world-renown German research center. Mr. Schumacher commented that just in the past week he had received over a dozen calls from U.S. and Canadian companies, research scientists, and investors, and that most (but not all) of the calls related to UST and the ability to use this novel technology platform to make nanoemulsions in the cannabis and other potentially lucrative fields of use.
The absorption of CBD from plant oil is a major problem that concerns many throughout the CBD industry. To that end, Mr. Schumacher stated, ”Companies are looking to make CBD oil water soluble in a natural way, one in which you do not need to add a lot of chemicals to make the oil soluble. That is exactly the path we are taking. We use physics (not chemistry) to break the CBD oil drops down to tiny nano-particles, which keeps them in solution. In addition, our recent data indicate that we do not lose or change any of the CBD in the starting material throughout the entire UST process. Those data are very important.”
Mr. Schumacher then stated that the Company had released data on February 21st to prove that the UST method had sheared the Hemp Oil down to tiny, nano-particles and that no CBD was lost or changed in the process.
Mr. Schumacher closed by stating, ”We’re not a cannabis company. We are a platform technology company. We believe our proprietary UST platform can help make many products better, not just in cannabis but in many additional industries as well, including cosmetics, pharmaceuticals, personal care products, and food and beverage. All of our recent successes, in both our new UST and in our existing PCT and BaroFold technology platforms, make us very excited for all stakeholders in PBIO.”
To hear Mr. Schumacher’s entire interview, follow the link to the podcast here: https://upticknewswire.com/featured-interview-ceo-ric-schumacher-of-pressure-biosciences-inc-otcqb-pbio-12/
Investors Hangout is a proud sponsor of ”Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired technology from BaroFold, Inc. (the “Barofold” technology) to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
For more information about PBI, please click on the following website link:
http://www.pressurebiosciences.com
Or please visit PBI on Facebook, LinkedIn, and Twitter.
Investor Contacts:
Richard T. Schumacher, President, and CEO (508) 230-1828 (T)
Bradford A. Young, Ph.D., MBA, Sr. VP & Chief Commercial Officer (508) 230-1829 (F)
About Uptick Newswire and the ”Stock Day” Podcast
Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets. Uptick is the sole producer of its ”Stock Day” Podcast, which is the number one radio show of its kind in America. The Uptick Network ”Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.
Uptick Newswire
602-441-3474
https://upticknewswire.com/
Palm Beach, FL – March 6, 2019 – Anyone who has been trying to keep abreast of where the cannabis markets are and where they may be going, revenue-wise, will have undoubtedly come across revenue projections in the headlines of almost every article. There is a reason for that. In fact, its because it seems that most, if not all projections, foreshadow all the ones that have come before. It seems as if every new report exceeds the projections from the previous report. Whether the numbers are right or wrong, they certainly paint a confident picture of future growth and more growth. One of the first such reports was discussed in The Rolling Stone, which said: “For years, experts have predicted that if the cannabis industry expands at its current rate, the American market will reach $20 billion by 2020. But it turns out that one market is spinning off into a mega-industry of its own: according to a new estimate from cannabis industry analysts, the hemp-CBD market alone could hit $22 billion by 2022. Active Companies from around the market with current developments this week include: Player’s Network, Inc. (OTC: PNTV), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Puration, Inc. (OTC: PURA), Namaste Technologies Inc. (TSX-V: N) (OTC: NXTTF).
A Forbes article, quoting another report, added: “…over the next 10 years, the legal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%. The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. The largest growth spread, however, is predicted within the rest-of-world markets, from $52 million spent in 2017 to a projected $2.5 billion in 2027.”
Player’s Network, Inc. (OTCQB: PNTV) BREAKING NEWS: Player’s Network, is in the process of changing its name to Green Leaf Farms International, Inc. PNTV/GLFI, a rapidly growing company in the worldwide cannabis market and CBD industries, with operations in Nevada and now Argentina, announced today that together with its Argentina joint venture partner, Cannava, it has received approval from the Argentine government to import cannabis seeds from the United States into Jujuy Province, Argentina.
This is the first time the Argentine government has approved such a venture. PNTV previously announced approval of seeds from a security standpoint, this approval, by the highest government agencies, was given exclusively to the joint venture with the goal of establishing Jujuy Province as the world’s leading supplier of cannabis oils, distillates, isolates, and biomass to a rapidly growing and underserved worldwide market.
As those knowledgeable of the industry know, there is an explosion of pharmaceutical, cosmetic, and health-related cannabis-infused products entering the global marketplace. At the present time most of these products are being introduced by small, start-up companies, although press reports indicate that the market demand is becoming so large and expanding so rapidly that a number of Fortune 500 companies in a wide range of industries including soft drink, adult beverage, cosmetic, pharmaceutical, and other health related industries are developing their own CBD-infused products.
This greatly increased demand for cannabis raw materials – CBD (and in some countries THC) Oils, Distillates and Isolates – will soon make these a commodity like other agricultural products. The company that dominates this market niche will be the one that establishes itself as the lowest cost, highest quality, reliable supplier. That supplier will be Green Leaf Farms International!
As previously announced, working in partnership with Jujuy Province, GLFI and its joint venture partner have negotiated a 99-year lease on 14,000 hectares or 34,600 acres (54 square miles) of prime agricultural land. The temperate climate near the equator allows virtually year-round growing conditions. In addition, working with the Argentine government, a tax-free trade zone has been established for the processing and worldwide distribution of the cannabis oils, distillates, isolates, and biomass grown on this land. Due to the quality of the land, ideal year-round growing conditions, low-cost agriculturally skilled labor force and, most importantly, absence of burdensome regulations and taxes, the company believes this joint venture with Argentina positions it to produce the highest quality, lowest cost raw materials that will enable GLFI to be the dominant player in this exploding worldwide market. Read this entire press release and more news for PNTV at: https://www.financialnewsmedia.com/news-pntv/
In the industry developments and happenings in the market this week include:
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB.TO) this week announced that it has completed the acquisition of all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation (“Whistler”), in an all-share transaction (the “Transaction”), pursuant to the terms of an amalgamation agreement dated January 31, 2019 among Whistler , Aurora, and a wholly owned subsidiary of Aurora (the “Agreement”).
Located in Whistler, British Columbia , Whistler has developed one of Canada’s most iconic cannabis brands, built on quality, award-winning, organic certified BC bud. The Transaction provides Aurora with a premium and differentiated organic certified product suite, expanding both its medical and consumer offerings, and reinforcing Aurora’s presence in the well-established west coast cannabis market.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) announced that it has received organic certification from Pro-cert Organic Systems Ltd. (“Pro-cert”). This is the second certification body to endorse TGOD’s organic process at its Hamilton facility.
The Company is committed to the highest standards of organic cultivation of cannabis. TGOD cannabis is grown in soil, without synthetic fertilizers, herbicides or pesticides, and is never irradiated. Canadian consumers have stated that they prefer organic cannabis. In a recent study conducted by Hill & Knowlton, over 50% of recreational consumers stated it was important that their cannabis was organic. When the same question was posed of medical patients, that number increased to 63%.
“Certified-organic provides consumers with the best cannabis experience, and the entire TGOD organization is committed to that standard,” said Brian Athaide, Director and CEO of TGOD. “The certification from Pro-Cert, along with the earlier certification from ECOCERT means that both leading organic certification bodies have approved our process. This is testimony to the work of David Bernard-Perron, Vice President, Growing Operations, and the entire cultivation and Operations team in Hamilton.”
Puration, Inc. (OTCPK: PURA) On March 5 announced that it has scheduled an online presentation, this Thursday, March 7th, 2019 to review new orders, opportunities and partnerships stemming from the EVERx CBD Sports Water event this past weekend at the Arnold Sports Festival. EVERx CBD Sports Water debuted its all new formula and packaging at the world-renowned Arnold Sports Festival this week in Columbus, Ohio where EVERx launched for the first time ever in 2017. The presentation will include updates on PURA’s work with Kali-Extracts (KALY) to formulate a 25 mg CBD infused beverage. The presentation will also include highlights on new cannabis infused products the two companies are working to develop.
Namaste Technologies Inc. (TSX-V: N.V) (OTCQB: NXTTF) in February announced that it had reached a mutually agreed upon settlement with Sean Dollinger resulting in Mr. Dollinger entering into an advisory relationship with Namaste providing transition support to the Company to ensure the best interests of the business and stakeholders are met (the “Agreement”). Pursuant to the Agreement, Mr. Dollinger has withdrawn his previously announced legal application against the Company and has agreed to step down from all formal roles with the Company, including as a director, which will also enable him to spend more time with his young family and pursue other opportunities. Meni Morim remains Interim Chief Executive Officer (“CEO”) of Namaste.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued by Player’s Network, Inc. by the company. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Following the recommendations by the World Health Organization (“WHO”) that whole-plant cannabis and its resin should be reclassified, the U.S. FDA has issued a notice asking interested parties to submit their views on this matter so that the position that the U.S. takes when the matter comes up for a vote at the UN is informed by the views collected.
While this is the third time that the federal government is asking stakeholders for input on marijuana rescheduling, it is the first time that they are doing so from the time WHO released its recommendations.
The World Health Organization observed that the evidence that was presented before its expert committee didn’t show that marijuana deserved to be in the same category as the other substances in Schedule IV of the treaty setting up guidelines on how various substances should be controlled internationally.
The UN body also made it clear that CBD, one of components of cannabis, should not be subjected to any international controls.
Additionally, the World Health Organization admitted that cannabis and its derivatives had demonstrated therapeutic benefits for a number of conditions, such as pain and multiple sclerosis.
The FDA explained that interested people would have up to March 14 to submit their views for consideration. This deadline was set based on an earlier timeline for the planned meeting of the UN Commission on Narcotic Drugs. That meeting is expected to be held anywhere between March 14 and March 22 this year.
That original timeline was set because the WHO was expected to release its recommendations in December last year. However, that didn’t happen for unknown reasons.
The FDA therefore expects to extend the period within which members of the public and other stakeholders in the U.S. can submit their comments if the UN communicates that the Narcotics Committee will sit at a later time. The alternative dates for that meeting are in December this year or March next year.
The views collected by the FDA will be analyzed and the findings forwarded to the Department of Health and Human Services. HHS will then formulate a recommendation of the position that the U.S. State Department should take when the matter of reclassification comes up for a vote at the UN.
This call for public comments provides a golden chance for stakeholders to play a role in shaping how the federal government will vote on the matter at the UN. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) call upon everyone with an interest in the cannabis industry to share their views with the FDA so that the U.S. can vote in a way that reflects the wishes of the people back home.
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) through its wholly-owned subsidiary, Canna Farms Limited, this morning announced the launch of Canna Farms’ integrated online medical cannabis website. As one of the largest online platforms for medical cannabis users across Canada, the store offers products from various cultivators including offerings from the Beacon Medical(TM) and Canna Farms(TM) brands. With more than 40 different cannabis strains and 100 different SKUs, the site is available immediately to registered medical cannabis patients. In addition, VIVO also announced that Daniel Laflamme has been appointed as Chief Operations Officer of the company. Laflamme will continue his role as a director of the company and as president of Canna Farms. “Canna Farms’ integrated online store will cater to discerning medical cannabis consumers,” Canna Farms president Daniel Laflamme stated in the news release. “In addition to offering award-winning Canna Farms and Beacon Medical brands, the site will serve as a marketplace for products from other licensed producers who share VIVO’s commitment to delivering premium products and services focused on health and wellness.”
To view the full press release, visit: http://nnw.fm/Sm98H
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
TORONTO, March 5, 2019 – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that it has received organic certification from Pro-cert Organic Systems Ltd. (“Pro-cert”). This is the second certification body to endorse TGOD’s organic process at its Hamilton facility.
The Company is committed to the highest standards of organic cultivation of cannabis. TGOD cannabis is grown in soil, without synthetic fertilizers, herbicides or pesticides, and is never irradiated. Canadian consumers have stated that they prefer organic cannabis. In a recent study conducted by Hill & Knowlton, over 50% of recreational consumers stated it was important that their cannabis was organic. When the same question was posed of medical patients, that number increased to 63%.
“Certified-organic provides consumers with the best cannabis experience, and the entire TGOD organization is committed to that standard,” said Brian Athaide, Director and CEO of TGOD. “The certification from Pro-Cert, along with the earlier certification from ECOCERT means that both leading organic certification bodies have approved our process. This is testimony to the work of David Bernard-Perron, Vice President, Growing Operations, and the entire cultivation and Operations team in Hamilton.”
Pro-Cert is one of North America’s foremost certification bodies, with a client base including producers, processors and traders from across Canada and the United States. Pro-Cert’s certification programs are ISO 17065 compliant and accredited, providing global recognition and international access to the products that are certified. TGOD packaging will include the Pro-cert logo to convey the organic point of difference to consumers.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Forward-Looking Information Cautionary Statement
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about future production, statements about the offering of any particular products by the Company in any jurisdiction, and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.
Lexaria Nicotine LLC, a subsidiary of Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), recently secured research and development (“R&D”) funding in exchange for equity and licensing rights. Utilizing its DehydraTECH absorption platform, Lexaria will execute a wide-ranging series of clinical studies on oral forms of nicotine delivery. A recent article discussing the company reads, “Under an investment agreement by its wholly owned subsidiary, Lexaria Nicotine LLC, a partner, will provide $1 million toward research on nicotine consumer products that use DehydraTECH(TM) (http://nnw.fm/A0iyv). . . Lexaria’s partner will receive certain licensing rights to commercialize these DehydraTECH products exclusively in the United States and nonexclusively on a global scale. The partner, which will have the option to provide up to $12 million in additional funding to underwrite LXRP’s R&D, will pay LXRP a royalty on sales. The partner company will receive minority equity in the subsidiary and future rights to purchase a 100 percent interest in Lexaria Nicotine LLC at then-current fair market value but not in LXRP itself.”
To view the full article, visit: http://nnw.fm/P89i4
About Lexaria Bioscience Corp.
Lexaria Bioscience has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. Lexaria has 10 patents granted in the United States and Australia, and has filed over 50 patent applications worldwide across 10 patent families. Lexaria’s technology provides more rapid delivery to the bloodstream, as well as important taste-masking benefits for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments and platform technologies for the life sciences and other industries worldwide, today announced its entry into a collaboration with world-renowned German research organization The Steinbeis Centre for Biopolymer Analysis & Biomedical Mass Spectrometry. The collaboration seeks to combine unique capabilities of PBIO’s patented pressure cycling technology (“PCT”) for sample preparation, protein characterization and biotherapeutics quality control with the Steinbeis Centre’s innovative PROTEX-MS instrument for elucidating structural details of antibody interactions to create a novel instrument system designed to accelerate the development of new protein therapeutics and improve existing drug treatments.
“This work has very important clinical applications, as it may help to develop more effective protein drugs with reduced side-effects in cancer, auto-immune, neurodegenerative, and other critical diseases and conditions,” PBIO Chief Commercial Officer Dr. Bradford A. Young stated in the news release. “We are honored that Dr. Przybylski and his team have incorporated our proprietary PCT platform as a critical component of this innovative solution. The results of this collaboration will provide PBI with another valuable and broad application area for our Barocycler instruments, and we anticipate this new instrument system will be of great interest to both current and future customers in the monoclonal antibody therapeutics market, expected to reach $218.97 billion by the end of 2023 (Zion Market Research, 2018).”
To view the full press release, visit: http://nnw.fm/5qTK1
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI) announced on Thursday that its wholly-owned subsidiary, Khrysos Industries, has closed on a 45-acre area of land in Central Florida. The multi-purpose site will hold a 5-acre greenhouse, a research and development (“R&D”) facility committed to hemp plant genetic research, a post processing tolling facility, and 20 acres of farmable land for future use. In addition, the company has leased an 8,800 square foot facility in Central Florida to serve as the assembly, manufacturing, and production facility for Khrysos’ one-ton Hyper Supercritical extraction systems. “This is an exciting time for Khrysos Industries as we focus on capitalizing on the shortage of production of non-THC oil into isolate and distillate and begin to address the growing shortage of quality tissue culturing and seed availability within the hemp industry. The pre-fabricated buildings are scheduled to be delivered to the site in the middle of March and the 5-acre greenhouse will begin to be assembled in early April. We anticipate pre-production processing beginning on a small scale in early April and ramping up to full production with our end-to-end system in early July,” Khyrsos Industries president Dwayne Dundore stated in the news release. “We anticipate that our genetics research facility and our greenhouse production capabilities will be at full-scale in the production of tissue culturing and quality hemp seeds as we move into the 2020 growing season.”
To view the full press release, visit: http://nnw.fm/0waTj
About Youngevity International, Inc.
Youngevity International, Inc. is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Emerging business development technology innovator Pacific Software (OTC: PFSF) is leveraging its proprietary BOAPIN cross-border blockchain trading platform as the centerpiece of a new partnership with China and FIERO, a leading Brazilian trade association focused on developing and promoting the economy of Rondônia. A recent article discussing this reads, “BOAPIN is an e-commerce trade platform designed to foster streamlined information between China and agricultural suppliers in Brazil through its marketing logistics, smart contract technology, product certification, cross-border payment solutions and multilingual communication. PFSF plans to use its agri-blockchain technology to guarantee the transparency of trading transactions. BOAPIN’s revenue model is subscription based.”
To view the full article, visit: http://nnw.fm/hyH5K
About Pacific Software Inc.
Pacific Software (OTC: PFSF) is an emerging development technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is a designer, developer and commercial distributor of blockchain-based systems. The company intends to be uniquely positioned to deliver B2B and B2C blockchain solutions by utilizing IBM’s Hyperledger Blockchain Backend as a Service (BaaS) infrastructure for two key industries: agriculture, to target farm-to-table beef exports, and opioids/controlled substance management, to create a verifiable and trusted ledger between pharmaceutical manufacturers and consumers. For more information, visit the company’s website at www.PacificSoftwareInc.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
- TGOD’s 49.18 percent interest in Jamaican cannabis company Epican includes cultivation, extraction, manufacturing facilities and retail distribution licenses
- Expansion of production capacity on the 100-acre site is timed to build inventory by up to 14,000 kg to meet forecast retail demand
- Flagship Kingston retail location continues to increase in month-over-month sales growth
- Company is testing the first high-tech medical cannabis vending machines using built-in biometric security features
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, and its Jamaican partner, Epican Medicinals Ltd. (“Epican”), are celebrating significant milestones toward establishing a leadership position in the island nation’s robust medical cannabis market. TGOD’s strategic partnership with Epican, first announced in June 2018 as an investment for a 49.18 percent interest in the company, serves the medical cannabis needs of Jamaica’s three million residents and nearly 4.3 million tourists (http://nnw.fm/Rg69A).
The relationship has been marked by nonstop highs for the partners, Brian Athaide, director and CEO of TGOD, stated in a news release…
Read more »
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive instant SMS alerts, text STOCKS to 77948
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com